Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Operating Expenses: 2009-2024

Historic Operating Expenses for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $44.3 million.

  • Cumberland Pharmaceuticals' Operating Expenses fell 4.85% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.5 million, marking a year-over-year decrease of 6.34%. This contributed to the annual value of $44.3 million for FY2024, which is 9.79% down from last year.
  • Cumberland Pharmaceuticals' Operating Expenses amounted to $44.3 million in FY2024, which was down 9.79% from $49.1 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Operating Expenses registered a high of $49.1 million during FY2023, and its lowest value of $43.7 million during FY2021.
  • Its 3-year average for Operating Expenses is $47.0 million, with a median of $47.7 million in 2022.
  • In the last 5 years, Cumberland Pharmaceuticals' Operating Expenses grew by 9.28% in 2022 and then fell by 9.79% in 2024.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Operating Expenses stood at $43.8 million in 2020, then declined by 0.37% to $43.7 million in 2021, then grew by 9.28% to $47.7 million in 2022, then climbed by 2.92% to $49.1 million in 2023, then dropped by 9.79% to $44.3 million in 2024.